Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented ...
Jun 1, 2024
0
1
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30, 2024
0
0
Pelvic health is crucial to a woman's overall well-being but is often misunderstood or overlooked. When symptoms such as urinary incontinence, pain or discomfort, or pain during intercourse occur, they are dismissed as a ...
May 29, 2024
0
0
In contemporary society, obesity has emerged as a worldwide chronic metabolic disorder, imposing substantial burdens on both individual health and health care systems. The insulin resistance that accompanies obesity poses ...
May 29, 2024
0
0
The average age at menarche—the first menstrual period—has been decreasing among younger generations in the U.S., especially those belonging to racial minorities and lower socioeconomic statuses, according to a new study ...
May 29, 2024
0
16
Anti-obesity drugs such as Ozempic were the "breakthrough of the year" in 2023, according to the AAAS journal Science. Overweight and obesity rates are rising worldwide, with several Latin American countries in the forefront. ...
May 29, 2024
0
0
The harmful combination of abdominal obesity and reduced muscle strength, also known as sarcopenic obesity, is already present in primary school children. This is shown by a new study among eight-year-olds, conducted at Karolinska ...
May 28, 2024
0
0
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular ...
May 25, 2024
0
1
Adolescents with overweight or obesity may be more vulnerable to negative cognitive effects following sleep restriction, according to a study published online May 20 in JAMA Neurology.
May 23, 2024
0
0
In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.
May 22, 2024
0
0
